Cargando…

Peripheral versus central mechanisms of the cannabinoid type 2 receptor agonist AM1710 in a mouse model of neuropathic pain

The CB(2)R agonist AM1710, examined in animal models of peripheral neuropathy, is effective in controlling aberrant light touch sensitivity, referred to as mechanical allodynia. However, nonspecific binding of AM1710 to CB(1)R, either peripherally or centrally, could be partially responsible for the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wilkerson, Jenny L., Alberti, Lauren B., Kerwin, Audra A., Ledent, Catherine A., Thakur, Ganesh A., Makriyannis, Alexandros, Milligan, Erin D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749576/ https://www.ncbi.nlm.nih.gov/pubmed/32977358 http://dx.doi.org/10.1002/brb3.1850

Ejemplares similares

Immunofluorescent spectral analysis reveals the intrathecal cannabinoid agonist, AM1241, produces spinal anti-inflammatory cytokine responses in neuropathic rats exhibiting relief from allodynia
por: Wilkerson, Jenny L, et al.
Publicado: (2012)

Improvement of spinal non-viral IL-10 gene delivery by D-mannose as a transgene adjuvant to control chronic neuropathic pain
por: Dengler, Ellen C, et al.
Publicado: (2014)

Cannabinoids Alleviate Experimentally Induced Intestinal Inflammation by Acting at Central and Peripheral Receptors
por: Fichna, Jakub, et al.
Publicado: (2014)

Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery
por: Rahn, Elizabeth J, et al.
Publicado: (2014)

Charité 1710–1985
por: Granshaw, Lindsay
Publicado: (1986)

AGREEMENT K1710
por: The European Organisation for Nuclear Research, CERN, et al.
Publicado: (2010)

The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB(2) receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy
por: Deng, Liting, et al.
Publicado: (2012)

PM288. Preclinical Evaluation of Neutral Cannabinoid CB1 Receptor Antagonists and Cannabinoid CB1 Receptor Negative Allosteric Modulators for Treating Drug Addiction
por: Gardner, Eliot L., et al.
Publicado: (2016)

Effects of a Selective Cannabinoid CB2 Agonist and Antagonist on Intravenous Nicotine Self Administration and Reinstatement of Nicotine Seeking
por: Gamaleddin, Islam, et al.
Publicado: (2012)

On the B(1235) and $\rho$ (1710) production on nuclei
por: Arnold, R, et al.
Publicado: (1973)

Expression, Purification and Characterization of the Human Cannabinoid 1 Receptor
por: Mallipeddi, Srikrishnan, et al.
Publicado: (2018)

Medicinal chemistry of cannabinoids
por: Vemuri, V Kiran, et al.
Publicado: (2015)

AM281, Cannabinoid Antagonist/Inverse agonist, Ameliorates Scopolamine-Induced Cognitive Deficit
por: Rabbani, Mohammed, et al.
Publicado: (2012)

The Cannabinoid Receptor 1 Reverse Agonist AM251 Ameliorates Radiation-Induced Cognitive Decrements
por: Parihar, Vipan K., et al.
Publicado: (2021)

Abraham Trembley of Geneva; Scientist and Philosopher, 1710-1784
por: Forbes, Thomas R.
Publicado: (1954)

Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain
por: Hossain, Mohammad Zakir, et al.
Publicado: (2020)

Cannabinoid CB(1) Receptors Inhibit Gut-Brain Satiation Signaling in Diet-Induced Obesity
por: Argueta, Donovan A., et al.
Publicado: (2019)

The spin of the $f_{J}(1710)$ and new effects observed in the WA102 experiment
por: Kirk, A.
Publicado: (1999)

Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite
por: Honrao, Chandrashekhar, et al.
Publicado: (2020)

1710. Profiling Patients with Rare Mucormycosis Infections Using Real-world Data
por: Sung, Anita H, et al.
Publicado: (2019)

Corrigendum: Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite
por: Honrao, Chandrashekhar, et al.
Publicado: (2021)

William Heberden the elder (1710-1801): aspects of his London practice.
por: Heberden, E
Publicado: (1986)

Novel Electrophilic and Photoaffinity Covalent Probes for Mapping the Cannabinoid 1 Receptor Allosteric Site(s)
por: Kulkarni, Pushkar M., et al.
Publicado: (2015)

Cannabinoid Agonists Inhibit Neuropathic Pain Induced by Brachial Plexus Avulsion in Mice by Affecting Glial Cells and MAP Kinases
por: Paszcuk, Ana F., et al.
Publicado: (2011)

Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain
por: Toth, Cory C, et al.
Publicado: (2010)

Chain Substituted Cannabilactones with Selectivity for the CB2 Cannabinoid Receptor
por: Alapafuja, Shakiru O., et al.
Publicado: (2019)

Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG‐018
por: Finlay, David B., et al.
Publicado: (2022)

Expression and Function of Cannabinoid Receptors CB1 and CB2 and Their Cognate Cannabinoid Ligands in Murine Embryonic Stem Cells
por: Jiang, Shuxian, et al.
Publicado: (2007)

Antiallodynic Effects of Cannabinoid Receptor 2 (CB(2)R) Agonists on Retrovirus Infection-Induced Neuropathic Pain
por: Sheng, Wen S., et al.
Publicado: (2019)

The CB(1) Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability
por: Gueye, Aliou B., et al.
Publicado: (2016)

Effects of various cannabinoid ligands on choice behaviour in a rat model of gambling
por: Gueye, Aliou B., et al.
Publicado: (2016)

A Pilot Study into the Effects of the CB1 Cannabinoid Receptor Agonist WIN55,212-2 or the Antagonist/Inverse Agonist AM251 on Sleep in Rats
por: Goonawardena, Anushka V., et al.
Publicado: (2011)

1710. Clostridioides difficile Bundle Implementation Reduces Unnecessary Testing in Pediatric Patients
por: Sietsema, Lydia, et al.
Publicado: (2023)

A peripheral CB(2) cannabinoid receptor mechanism suppresses chemotherapy-induced peripheral neuropathy: evidence from a CB(2) reporter mouse
por: Lin, Xiaoyan, et al.
Publicado: (2022)

Effects of the CB1 Receptor Antagonists AM6545 and AM4113 on Insulin Resistance in a High-Fructose High-Salt Rat Model of Metabolic Syndrome
por: Eid, Basma G., et al.
Publicado: (2020)

Role of the Endogenous Cannabinoid System in Nicotine Addiction: Novel Insights
por: Gamaleddin, Islam Hany, et al.
Publicado: (2015)

Sex Differences in a Rat Model of Peripheral Neuropathic Pain and Associated Levels of Endogenous Cannabinoid Ligands
por: Boullon, Laura, et al.
Publicado: (2021)

Synthetic Cannabinoid Receptor Agonists Detection Using Fluorescence Spectral Fingerprinting
por: May, Benedict, et al.
Publicado: (2019)

El monopolio estatal del mercurio en el México colonial, 1550-1710 /
por: Lang, M. F. (Mervyn F.)
Publicado: (1977)

Abstract: 17.10 Development Of A Novel Digital Image System In Plastic Surgery
por: Bonde, Christian, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uk95hkspl50bipmgn40tqhutav